Brief: Aquestive Therapeutics Expands License And Supply Agreement With Pharmanovia For Libervant™ (Diazepam) Buccal Film To Additional Global Markets

Aquestive Therapeutics

29/03/2023 13:34

March 29 (Reuters) - Aquestive Therapeutics Inc
 AQST.O :
    * AQUESTIVE THERAPEUTICS EXPANDS LICENSE AND SUPPLY
AGREEMENT WITH
PHARMANOVIA FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM TO ADDITIONAL
GLOBAL MARKETS
    * AQUESTIVE THERAPEUTICS INC - EXPANDED ITS EXCLUSIVE
LICENSE AND
SUPPLY AGREEMENT WITH ATNAHS PHARMA UK LIMITED
    * AQUESTIVE THERAPEUTICS INC - AGREEMENT EXTENDS AND EXPANDS
LIFECYCLE OF ESTABLISHED MEDICINES
    * AQUESTIVE THERAPEUTICS - AGREEMENT EXTENDS & EXPANDS
LIBERVANT
BUCCAL FILM TO COVER REST OF WORLD, EXCLUDING UNITED STATES,
CANADA, AND CHINA
    * AQUESTIVE THERAPEUTICS INC - PURSUANT TO EXPANDED
AGREEMENT,
AQUESTIVE THERAPEUTICS WILL SERVE AS EXCLUSIVE SOLE MANUFACTURER
AND SUPPLIER FOR PRODUCT
    * AQUESTIVE THERAPEUTICS INC - PHARMANOVIA WILL BE
RESPONSIBLE FOR
ALL REGULATORY AND COMMERCIALIZATION ACTIVITIES FOR PRODUCT
    * AQUESTIVE THERAPEUTICS INC - AQUESTIVE WILL RECEIVE AN
UNDISCLOSED UPFRONT PAYMENT
    * AQUESTIVE THERAPEUTICS INC -  WILL RECEIVE AN DOUBLE-DIGIT
ROYALTIES ON NET SALES OF DIAZEPAM BUCCAL FILM IN LICENSED
TERRITORIES

Source text for Eikon:  ID:nGNX9ZCN3h 
Further company coverage:  AQST.O 

 ((Reuters.Briefs@thomsonreuters.com;;))